4 Top Biotech Stocks With Big Upcoming Catalysts
In a new report, SunTrust Robinson Humphrey analysts are focused on upcoming catalysts for biotech stocks in their coverage universe.
Archive
Year: 2017
All Year: 2017 Articles
Newest first · Page 456
How Eli Lilly Earnings Won Big on New Drug Sales
Eli Lilly released a mixed fourth-quarter earnings report and offered full-year guidance before the markets opened on Tuesday.
Why Exxon Mobil Earnings Tumbled 40%
Exxon earnings were a little worse than expected, but investors apparently believe that the recent acquisition of Permian Basin acreage is major positive going forward.
Top Analyst Upgrades and Downgrades: BP, Fitbit, Randgold, SLM, Teva, T-Mobile, GoPro and Many More
The top analyst upgrades, downgrades and initiations seen on Tuesday include BP, Fitbit, Randgold Resources, SLM, Teva Pharmaceuticals, T-Mobile and GoPro.
Are Pfizer’s Acquisitions Holding Back Its Bottom Line?
When Pfizer reported its fourth-quarter financial results before the markets opened on Tuesday, earnings fell short of consensus estimates.
Merrill Lynch Says 5 Companies Could Benefit Huge From Trump Tax Plan
Five companies with stocks rated Buy at Merrill Lynch and that do all of their business in the United States, which is critical, given the stronger dollar.
Where Does Under Armour Go From Here?
Under Armour stock headed for new 52-week low after weak earnings report and the ouster of company's chief financial officer.
Wedbush’s 6 Best Idea Stocks for 50% Upside (or Much More)
Wedbush has issued a report with some of its best ideas for 2016. These top six ideas from this list have implied upside of at least 50%.
Boeing, Lockheed May Duel Alone for Air Force Training Jet
Northrop Grumman may pull out of the competition for the new Air Force T-X training jet, leaving only Boeing and Lockheed Martin as certain competitors for the program.
Despite Quality Awards, Chevy Offers Steep Discounts
The current major marketing campaign for Chevrolet talks about the record number of quality awards it has received recently. The awards did not help its sales last year.
College Endowment Values Dropped in 2016, Despite Market Rise
The bull market has not helped the value of college and university endowments. Those funds are at their lowest since the recession.
Uber Knocks Value of NYC Cab Medallions Further as Some Owners File for Bankruptcy
Cab medallions in New York City have dropped below $400,000 in some cases as Uber continues to dismantle the market.
Rite Aid, Fitbit Plunge into Monday’s 52-Week Low Club
Rite Aid, Fitbit, Penney's, Tempur Sealy post new 52-week lows on Monday.
DuPont, Caterpillar Tank DJIA Monday
Caterpillar, DuPont, Chevron, and Boeing sink the DJIA on Monday.
Is This the Beginning of EyeGate’s Rally?
Eyegate Pharmaceuticals, Inc. (NASDAQ: EYEG) saw its shares rise handily on Monday following positive top-line results from the company’s first-in-human pilot trial. Specifically, the trial is for the EyeGate Ocular Bandage Gel (OBG) for…